Search
news › new-times-for-community-outreach-play
… The Dan L Duncan Cancer Center’s 2011 community outreach play schedule has been changed. See … 7037 Capitol Street Houston, Texas 77011 The play is performed in Spanish. Following the performances, colorectal cancer experts will be on hand to … showtimes announced for Dan L Duncan Cancer Center 2011 community outreach play …
news › koch-honor-society-for-blind-visually-impaire
… recognized award given annually by St. Louis Society for the Blind and Visually Impaired . Koch, the Allen, … St. Louis Society for the Blind and Visually Impaired has been awarding this … the world¹s most highly respected scholars and clinicians for commendable service in eyesight research, ophthalmology, …
research › research-centers › center-for-lysosome-regulation-and-signaling-research-in-aging-and-alzheimers-disease
… responsibility of clearing waste materials. It does so by communicating the cell's needs with the nucleus so that it … We are working to understand how the lysosome manages these complex tasks in the healthy brain and how dysfunction of … a listing of publications from the members of the Center for Lysosome Regulation and Signaling Research in Aging and …
healthcare › clinical-trials › h-46373
… if patients undergoing a minimally invasive surgery for early stage uterine cancer have cancer cells in the … patients who do not have a uterine manipulator placed. For more information: https://clinicaltrials.gov/study/NCT04586959 … Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer …
news › baylor-researchers-awarded-1-6m-to-investigate-mass-spec-test-for-thyroid-cancer
… in funding to validate a mass spectrometry-based test for diagnosis of thyroid fine needle aspiration (FNA) … a final diagnosis which is associated with risk, cost, and complications for the patient. In 2019, Dr. Eberlin and Dr. Suliburk … Researchers Awarded $1.6M to Investigate Mass Spec Test for Thyroid Cancer …
healthcare › clinical-trials › h-47159
… Biomarker In Patients Undergoing Neoadjuvant Therapy For Resectable Non-Small Cell Lung Cancer … of employing quantitative ctDNA as a surrogate marker for pathologic treatment response in patients receiving neoadjuvant therapy for Stage IIA-IIIB NSCLC undergoing curative-intent …
news › broadly-diverse-genomes-study-reveals-new-susceptibility-genetic-variants-for-lung-cancer
… College of Medicine identifies new genetic risk factors for lung cancer. The cross-ancestry genome-wide association … tended to be specific to populations. Even some commonly known risk factors such as the CHRNA5 and CYP2A6 … for population and quantitative science at the Dan L Duncan Comprehensive Cancer Center at Baylor. For a full list of …
news › clinical-trial-to-improve-prognosis-for-pancreatic-cancer-patients-now-enrolling-patients
… medical director of medical oncology at the Dan L Duncan Comprehensive Cancer Center, are now enrolling patients in a … clinical trial with the potential to improve the prognosis for patients with pancreatic cancer. “Through this study, … in cancers such as lung and breast cancer have shown that a combination of immune checkpoint therapy administered …
news › study-shows-synergistic-association-between-genetic-and-behavioral-risks-for-liver-disease
… alcohol use and obesity are known to increase the risk for developing cirrhosis and liver cancer, but the risk is not the same for everyone with those factors. Researchers at Baylor … PNPLA3, plays a synergistic role in increasing the risk for cirrhosis, liver cancer and liver-related death when …
news › simple-rapid-and-robust-method-makes-mouse-whole-organs-transparent-for-imaging
… The adage ‘Seeing is believing’ was front of mind for Dr. Chih-Wei Logan Hsu and Dr. Joshua D. Wythe at Baylor … Cancer Center and the Cardiovascular Research Institute . “For instance, researchers can now visualize neuronal … said. “Then, they can bring the cleared organ to the OiVM for 3D imaging and analysis.” Other contributors to this …